AusPAR: Rybelsus

Australian Public Assessment Report

AusPAR

AusPAR: Rybelsus [PDF, 1.44 MB]

AusPAR: Rybelsus [Word, 3.87 MB]

AusPAR Attachment 1: Product Information for Rybelsus [PDF, 453.07 KB]

AusPAR Attachment 1: Product Information for Rybelsus [Word, 286.48 KB]

Device/Product Name

Rybelsus

Active ingredients

Semaglutide

AusPAR Date

27 October 2022

Published

11 November 2022

Submission Number

PM-2020-03921-1-5

Submission Type

New biological entity

Decision

Approved